225 related articles for article (PubMed ID: 38597968)
1. [Importance of aspirin challenges in patients with NSAID-exacerbated respiratory disease].
Förster-Ruhrmann U; Olze H
HNO; 2024 Jul; 72(7):494-498. PubMed ID: 38597968
[TBL] [Abstract][Full Text] [Related]
2. [Nasal provocation with increased ASA dose: improved "non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated disease" (N‑ERD) detection rate in chronic rhinosinusitis patients].
Förster-Ruhrmann U; Behrbohm W; Pierchalla G; Szczepek AJ; Fluhr JW; Olze H
HNO; 2019 Aug; 67(8):620-627. PubMed ID: 31069402
[TBL] [Abstract][Full Text] [Related]
3. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
4. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
5. Nonsteroidal anti-inflammatory drugs-exacerbated respiratory disease in adolescents.
Ertoy Karagol HI; Yilmaz O; Topal E; Ceylan A; Bakirtas A
Int Forum Allergy Rhinol; 2015 May; 5(5):392-8. PubMed ID: 25755210
[TBL] [Abstract][Full Text] [Related]
6. Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
.
Förster-Ruhrmann U; Tietz AK; Kim J; Liebers U; Szczepek AJ; Olze H
Allergol Select; 2020; 4():135-143. PubMed ID: 33393939
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease.
Williams AN
Immunol Allergy Clin North Am; 2016 Nov; 36(4):657-668. PubMed ID: 27712761
[TBL] [Abstract][Full Text] [Related]
8. Aspirin hypersensitivity in patients with chronic rhinosinusitis and nasal polyposis: frequency and contributing factors.
Nabavi M; Esmaeilzadeh H; Arshi S; Bemanian MH; Fallahpour M; Bahrami A; Mortazavi N; Kamrava K; Farhadi M; Taghipour R; Rezaei N
Am J Rhinol Allergy; 2014; 28(3):239-43. PubMed ID: 24980235
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of NSAID-Exacerbated Respiratory Disease: has the time come for subphenotyping?
Kowalski ML
Curr Opin Pulm Med; 2019 Jan; 25(1):64-70. PubMed ID: 30489335
[TBL] [Abstract][Full Text] [Related]
10. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
Front Immunol; 2021; 12():695815. PubMed ID: 34305932
[TBL] [Abstract][Full Text] [Related]
11. Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?
Vaidyanathan S; Williamson PA; Lipworth BJ
Am J Rhinol Allergy; 2012; 26(3):e89-93. PubMed ID: 22643934
[TBL] [Abstract][Full Text] [Related]
12. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
O'Brien EK; Jerschow E; Divekar RD
Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
[TBL] [Abstract][Full Text] [Related]
13. Effect of LTRA in L-ASA Challenge for Aspirin-Exacerbated Respiratory Disease Diagnosis.
Ramírez-Jiménez F; Vázquez-Corona A; Sánchez-de la Vega Reynoso P; Pavón-Romero GF; Jiménez-Chobillon MA; Castorena-Maldonado AR; Teran LM
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1554-1561. PubMed ID: 33160093
[TBL] [Abstract][Full Text] [Related]
14. Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG; Simon HU; Schmitz-Schumann M
Acta Otorhinolaryngol Belg; 1995; 49(3):235-50. PubMed ID: 7484142
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper.
Kowalski ML; Agache I; Bavbek S; Bakirtas A; Blanca M; Bochenek G; Bonini M; Heffler E; Klimek L; Laidlaw TM; Mullol J; Niżankowska-Mogilnicka E; Park HS; Sanak M; Sanchez-Borges M; Sanchez-Garcia S; Scadding G; Taniguchi M; Torres MJ; White AA; Wardzyńska A
Allergy; 2019 Jan; 74(1):28-39. PubMed ID: 30216468
[TBL] [Abstract][Full Text] [Related]
16. [Not Available].
Borgeat Kaeser A; Ribi C
Praxis (Bern 1994); 2017; 106(22):1243-1249. PubMed ID: 29088964
[No Abstract] [Full Text] [Related]
17. Omalizumab-Induced Aspirin Tolerance in Nonsteroidal Anti-Inflammatory Drug-Exacerbated Respiratory Disease Patients Is Independent of Atopic Sensitization.
Quint T; Dahm V; Ramazanova D; Arnoldner MA; Kurz H; Janik S; Brunner PM; Knerer-Schally B; Weninger W; Griss J; Ristl R; Schneider S; Bangert C
J Allergy Clin Immunol Pract; 2022 Feb; 10(2):506-516.e6. PubMed ID: 34678497
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
Haque R; White AA; Jackson DJ; Hopkins C
J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID-ERD: Results from two randomized placebo-controlled phase 3 trials.
Mullol J; Laidlaw TM; Bachert C; Mannent LP; Canonica GW; Han JK; Maspero JF; Picado C; Daizadeh N; Ortiz B; Li Y; Ruddy M; Laws E; Amin N
Allergy; 2022 Apr; 77(4):1231-1244. PubMed ID: 34459002
[TBL] [Abstract][Full Text] [Related]
20. [Provocation tests in the diagnosis of acetylsalicylic acid intolerance].
Semik A; Barczyk A; Pierzchała W
Wiad Lek; 2005; 58(9-10):543-8. PubMed ID: 16529067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
